These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24415460)

  • 61. How Viral Sequence Analysis May Guide Development of Respiratory Syncytial Virus Monoclonal Antibodies.
    Langedijk AC; Bont LJ
    Clin Infect Dis; 2021 Dec; 73(11):e4409-e4410. PubMed ID: 32640025
    [No Abstract]   [Full Text] [Related]  

  • 62. Production and characterization of monoclonal antibodies against human ceruloplasmin.
    Eum WS; Choi HS; Kim DW; Jang SH; Choi SH; Kim SY; Park J; Kang JH; Cho SW; Kwon OS; Hwang IK; Yoo KY; Kang TC; Won MH; Choi SY
    J Biochem Mol Biol; 2005 Jan; 38(1):71-6. PubMed ID: 15715949
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B).
    Kremmer E; Kranz BR; Hille A; Klein K; Eulitz M; Hoffmann-Fezer G; Feiden W; Herrmann K; Delecluse HJ; Delsol G; Bornkamm GW; Mueller-Lantzsch N; Grässert FA
    Virology; 1995 Apr; 208(1):336-42. PubMed ID: 11831716
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Generation of an antibody against the protein phosphatase 1 inhibitor KEPI and characterization of the epitope.
    Daskalow K; Boisguerin P; Jandrig B; Van Landeghem FK; Volkmer R; Micheel B; Schenk JA
    Anticancer Res; 2010 May; 30(5):1573-8. PubMed ID: 20592344
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Seasonality in Respiratory Syncytial Virus Hospitalizations and Immunoprophylaxis.
    Kusma JD; Macy ML; Kociolek LK; Davis MM; Ramgopal S
    JAMA Health Forum; 2023 Jun; 4(6):e231582. PubMed ID: 37389862
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse-human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoprotein.
    Mekseepralard C; Toms GL; Routledge EG
    J Gen Virol; 2006 May; 87(Pt 5):1267-1273. PubMed ID: 16603529
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
    McGill A; Marsh R; Craft AW; Toms GL
    J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.
    Plotnicky-Gilquin H; Goetsch L; Huss T; Champion T; Beck A; Haeuw JF; Nguyen TN; Bonnefoy JY; Corvaïa N; Power UF
    J Virol; 1999 Jul; 73(7):5637-45. PubMed ID: 10364313
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
    Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Generation and epitope mapping of a sub-group cross-reactive anti-respiratory syncytial virus G glycoprotein monoclonal antibody which is protective in vivo.
    Robinson MJ; Tan CS; Fenwick F; Chambers CJ; Routledge EG; Toms GL
    J Med Virol; 2014 Jul; 86(7):1267-77. PubMed ID: 24415460
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Progress towards recombinant anti-infective antibodies.
    Pai JC; Sutherland JN; Maynard JA
    Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):1-17. PubMed ID: 19149692
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.